Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- MODAG GmbH
- Study ID
- NCT07640555
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Healthy Adult
- Multiple System Atrophy (MSA)
- Parkinson Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- [¹⁸F]MODAG-009 PET imaging — DRUGParticipants enrolled in the study will receive a single IV injection of \[¹⁸F\]MODAG-009 followed by dynamic PET imaging using the United Imaging NeuroEXPLORER (NX) brain PET scanner.
Study Details
This is a single-center, open-label clinical study designed to evaluate the imaging characteristics and safety of \[¹⁸F\]MODAG-009 in participants with Parkinson's disease (PD), Multiple system atrophy (MSA), and Healthy controls (HC). Approximately 13 participants will be enrolled in this study. Each participant will receive a single intravenous injection of \[¹⁸F\]MODAG-009, followed by PET imaging using the investigational United Imaging NeuroEXPLORER (NX) camera.
Key Dates
- Start date
- May 13, 2026
- Status verified
- May 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 13 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Parkinson's disease (PD); Multiple system atrophy (MSA); Healthy controls (HC)Participants enrolled in the study will receive a single IV injection of up to up to 8 mCi of \[¹⁸F\]MODAG-009.
Primary Outcome Measure
Standard Uptake Value Ratios (SUVR) [ Time Frame: Up to 3 hours after tracer injection. ]
Central Contacts
- Johannes Levin, MD475-318-8250 (24 hours)
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Institute for Neurodegenerative Disorders and XingImaging, LLC | New Haven | Connecticut | 06510 | Neha Prakash, MBBS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Haven, CT
By condition
By specialty
Related Studies
- PPMI Clinical - Establishing a Deeply Phenotyped PD CohortRecruiting · Michael J. Fox Foundation for Parkinson's Research · Birmingham, Alabama
- Intestinal Immunity in Neurologic DiseaseRecruiting · Yale University · North Haven, Connecticut
- Cognitive Effects of Exercise in Parkinson's DiseaseEnrolling By Invitation · Sule Tinaz · New Haven, Connecticut
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePHASE2/PHASE3 · Recruiting · Biohaven Therapeutics Ltd. · Birmingham, Alabama